AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 1.440
+0.050 (3.60%)
Jul 31, 2026, 3:59 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 1.77 billion as of July 31, 2026. Its market cap has decreased by -71.49% in one year.
Market Cap
1.77B
Enterprise Value
3.52B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.44
ChartMarket Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 1.77B, a decrease of -91.24%. That is a compound annual growth rate of -47.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.77B | -55.14% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laekna | 2.56B |
| BioDlink International Company | 2.48B |
| Frontage Holdings | 2.37B |
| PegBio | 2.10B |
| SinoMab BioScience | 1.89B |
| Mabpharm | 1.65B |
| HighTide Therapeutics | 1.49B |
| Zhaoke Ophthalmology | 1.36B |